Prospective Grant of Exclusive License: Devices for Countercurrent Chromatography, 2707-2708 [07-253]

Download as PDF rmajette on PROD1PC67 with NOTICES Federal Register / Vol. 72, No. 13 / Monday, January 22, 2007 / Notices Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4218, MSC 7812, Bethesda, MD 20892, (301) 435– 2778, wangjia@csr.nih.gov. Name of Committee: Immunology Integrated Review Group, Cellular and Molecular Immunology—B Study Section. Date: February 15–16, 2007. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Betty Hayden, PhD, Scientific ReviewAdministrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4206, MSC 7812, Bethesda, MD 20892, 301–435– 1223, haydenb@csr.nih.gov. Name of Committee: Health of the Population Integrated Review Group, Kidney, Nutrition, Obesity and Diabetes Study Section. Date: February 15–16, 2007. Time: 8:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Christopher T. Sempos, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3146 MSC 7770, Bethesda, MD 20892, (301) 451– 1329, semposch@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, BTSS Member Conflict ZRG1 SBIB–E (03) M. Date: February 15, 2007. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Roberto J. Matus, MD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD 20892, 301–435– 2204, matusr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, SRA Conflict-Cardiovascular Differentiation and Development. Date: February 16, 2007. Time: 10 a.m. to 11 a.m. Agenda: To review and evaluate grant applications. Place: Wyndham Washington, DC, 1400 M Street, NW., Washington, DC 20005. Contact Person: Lawrence E. Boerboom, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5156, MSC 7814, Bethesda, MD 20892, (301) 435– 8367, boerboom@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Psychopathology, Developmental Disabilities and Disorders of Aging. Date: February 19, 2007. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. VerDate Aug<31>2005 15:20 Jan 19, 2007 Jkt 211001 Place: Villa Florence Hotel, 225 Powell Street, San Francisco, CA 94102. Contact Person: Dana Jeffrey Plude, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3176, MSC 7848, Bethesda, MD 20892, 301–435– 2309, pluded@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Oncology Area. Date: February 19, 2007. Time: 10 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Lambratu Rahman, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, 301–451– 3493, rahmanl@csr.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group, Bacterial Pathogenesis Study Section. Date: February 20–21, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Watergate, 2650 Virginia Avenue, NW., Washington, DC 20037. Contact Person: Richard G. Kostriken, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 20892, 301–402– 4454, kostrikr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Cancer Diagnostic and Treatment II, SBIR/STTR. Date: February 20–21, 2007. Time: 8 a.m. to 11:55 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Hungyi Shau, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, 301–435– 1720, shauhung@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Cancer Diagnostic and Treatment I, SBIR/STTR. Date: February 20–21, 2007. Time: 8 a.m. to 11:50 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Hungyi Shau, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, 301–435– 1720, shauhung@csr.nih.gov. Name of Committee: Cardiovascular Sciences Integrated Review Group, Vascular Cell and Molecular Biology Study Section. Date: February 20–21, 2007. PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 2707 Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel and Executive Meeting Center, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Anshumali Chaudhari, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4124, MSC 7802, Bethesda, MD 20892, (301) 435– 1210, chaudhaa@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 12, 2007. David Clary, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–241 Filed 1–19–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Exclusive License: Devices for Countercurrent Chromatography National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive worldwide license to practice the invention embodied in: HHS Ref. No. E– 274–1998 ‘‘Chromatographic Separation Apparatus and Method,’’ U.S. Patent No. 6,379,973; HHS Ref. No. E–044– 1993 ‘‘Variable-Position Cross-Axis Synchronous Coil Plant Centrifuge for Countercurrent Chromatography;’’ U.S. Patent 5,380,429; HHS Ref. No. E–148– 2001 ‘‘Method and Apparatus for Countercurrent Chromatography;’’ U.S. Patent Application No. 10/509,697 filed April 5, 2002; to CC Biotech LLC, a company incorporated under the laws of the State of Maryland having its headquarters in Rockville, Maryland. The United States of America is the assignee of the rights of the above inventions. The contemplated exclusive license may be granted in a field of use limited to instrumentation for countercurrent chromatographic purification of proteins and peptides. DATES: Only written comments and/or applications for a license received by the NIH Office of Technology Transfer E:\FR\FM\22JAN1.SGM 22JAN1 2708 Federal Register / Vol. 72, No. 13 / Monday, January 22, 2007 / Notices on or before March 23, 2007 will be considered. ADDRESSES: Requests for a copy of the patent application, inquiries, comments and other materials relating to the contemplated license should be directed to: Michael A. Shmilovich, Esq., Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852–3804; Telephone: (301) 435– 5019; Facsimile: (301) 402–0220; E-mail: shmilovm@mail.nih.gov. A signed confidentiality nondisclosure agreement will be required to receive copies of any patent applications that have not been published by the United States Patent and Trademark Office or the World Intellectual Property Organization. SUPPLEMENTARY INFORMATION: The patents and patent applications intended for licensure disclose or cover the following: rmajette on PROD1PC67 with NOTICES E–274–1998, ‘‘Chromatographic Separation Apparatus and Method,’’ U.S. Patent No. 6,379,973 This invention pertains to an apparatus and method for separating bio-molecules using a salt (e.g., ammonium sulfate) gradient applied in a spiral flow channel divided by a dialysis membrane. The channels are compartmentalized into upper and lower rotary discs spinning anticlockwise to each other. Sample is introduced in a buffered solution into the lower channel flows in one direction while the salt flows in the other. The concentration of salt permeates the membrane and precipitates the large molecules on the other side. For example, proteins or polymers are precipitates sequentially in the channel and centrifugal forces the precipitate to the outer rim as it moves along the liquid stream. E–044–1993, ‘‘Variable-Position CrossAxis Synchronous Coil Planet Centrifuge for Countercurrent Chromatography,’’ U.S. Patent No. 6,379,973 This device is a cross-axis synchronous flow-through coil planet centrifuge which provides changeability in the position of the coils relative to the axis of rotation of the centrifuge. The advantage of this feature is to allow adjustment of the centrifugal force operating on the coils to accommodate different types of separations. The coils are arranged in columns which are mounted to column holders that in turn can be engaged to the rotary frame of the centrifuge in position in which the column holders intersect and do not intersect the rotary frame axis. This VerDate Aug<31>2005 15:20 Jan 19, 2007 Jkt 211001 arrangement allows for larger coils which can hold between 200 ml and 800 ml of sample. E–148–2001, ‘‘Method and Apparatus for Countercurrent Chromatography,’’ U.S. Patent Application No. 10/509,697 (WIPO publication 03/087807) This device and method is an improvement of the countercurrent chromatography devices described above. This patent pending device is a new spiral design capable of holding heavier solvent systems suitable for peptides and proteins (e.g., for natural products). The prospective exclusive license will be royalty bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within sixty (60) days from the date of this published notice, NIH receives written evidence and argument that establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Properly filed competing applications for a license filed in response to this notice will be treated as objections to the contemplated license. Comments and objections submitted in response to this notice will not be made available for public inspection, and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. Dated: January 12, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. 07–253 Filed 1–19–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services Agency Information Collection Activities: Extension of a Currently Approved Information Collection: Comment Request 60-day notice of information collection under review; application for posthumous citizenship; form N–644. OMB control number 1615–0059. ACTION: The Department of Homeland Security, U.S. Citizenship and Immigration Services has submitted the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 1995. The information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted for sixty days until March 23, 2007. Written comments and suggestions regarding the item(s) contained in this notice, and especially regarding the estimated public burden and associated response time, should be directed to the Department of Homeland Security (DHS), USCIS, Director, Regulatory Management Division, Clearance Office,111 Massachusetts Avenue, NW., 3rd Floor, Suite 3008, Washington, DC 20529. Comments may also be submitted to DHS via facsimile to 202– 272–8352, or via e-mail at rfs.regs@dhs.gov. When submitting comments by e-mail add the OMB Control Number 1615–0059 in the subject box. Written comments and suggestions from the public and affected agencies concerning the collection of information should address one or more of the following four points: (1) Evaluate whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Extension of a currently approved information collection. (2) Title of the Form/Collection: Application for Posthumous Citizenship. (3) Agency form number, if any, and the applicable component of the Department of Homeland Security sponsoring the collection: Form N–644, U.S. Citizenship and Immigration Services. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Individual or households. The information collected will be used to determine an applicant’s E:\FR\FM\22JAN1.SGM 22JAN1

Agencies

[Federal Register Volume 72, Number 13 (Monday, January 22, 2007)]
[Notices]
[Pages 2707-2708]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-253]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Prospective Grant of Exclusive License: Devices for 
Countercurrent Chromatography

AGENCY: National Institutes of Health, Public Health Service, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), 
Department of Health and Human Services, is contemplating the grant of 
an exclusive worldwide license to practice the invention embodied in: 
HHS Ref. No. E-274-1998 ``Chromatographic Separation Apparatus and 
Method,'' U.S. Patent No. 6,379,973; HHS Ref. No. E-044-1993 
``Variable-Position Cross-Axis Synchronous Coil Plant Centrifuge for 
Countercurrent Chromatography;'' U.S. Patent 5,380,429; HHS Ref. No. E-
148-2001 ``Method and Apparatus for Countercurrent Chromatography;'' 
U.S. Patent Application No. 10/509,697 filed April 5, 2002; to CC 
Biotech LLC, a company incorporated under the laws of the State of 
Maryland having its headquarters in Rockville, Maryland. The United 
States of America is the assignee of the rights of the above 
inventions. The contemplated exclusive license may be granted in a 
field of use limited to instrumentation for countercurrent 
chromatographic purification of proteins and peptides.

DATES: Only written comments and/or applications for a license received 
by the NIH Office of Technology Transfer

[[Page 2708]]

on or before March 23, 2007 will be considered.

ADDRESSES: Requests for a copy of the patent application, inquiries, 
comments and other materials relating to the contemplated license 
should be directed to: Michael A. Shmilovich, Esq., Office of 
Technology Transfer, National Institutes of Health, 6011 Executive 
Boulevard, Suite 325, Rockville, MD 20852-3804; Telephone: (301) 435-
5019; Facsimile: (301) 402-0220; E-mail: shmilovm@mail.nih.gov. A 
signed confidentiality nondisclosure agreement will be required to 
receive copies of any patent applications that have not been published 
by the United States Patent and Trademark Office or the World 
Intellectual Property Organization.

SUPPLEMENTARY INFORMATION: The patents and patent applications intended 
for licensure disclose or cover the following:

E-274-1998, ``Chromatographic Separation Apparatus and Method,'' U.S. 
Patent No. 6,379,973

    This invention pertains to an apparatus and method for separating 
bio-molecules using a salt (e.g., ammonium sulfate) gradient applied in 
a spiral flow channel divided by a dialysis membrane. The channels are 
compartmentalized into upper and lower rotary discs spinning anti-
clockwise to each other. Sample is introduced in a buffered solution 
into the lower channel flows in one direction while the salt flows in 
the other. The concentration of salt permeates the membrane and 
precipitates the large molecules on the other side. For example, 
proteins or polymers are precipitates sequentially in the channel and 
centrifugal forces the precipitate to the outer rim as it moves along 
the liquid stream.

E-044-1993, ``Variable-Position Cross-Axis Synchronous Coil Planet 
Centrifuge for Countercurrent Chromatography,'' U.S. Patent No. 
6,379,973

    This device is a cross-axis synchronous flow-through coil planet 
centrifuge which provides changeability in the position of the coils 
relative to the axis of rotation of the centrifuge. The advantage of 
this feature is to allow adjustment of the centrifugal force operating 
on the coils to accommodate different types of separations. The coils 
are arranged in columns which are mounted to column holders that in 
turn can be engaged to the rotary frame of the centrifuge in position 
in which the column holders intersect and do not intersect the rotary 
frame axis. This arrangement allows for larger coils which can hold 
between 200 ml and 800 ml of sample.

E-148-2001, ``Method and Apparatus for Countercurrent Chromatography,'' 
U.S. Patent Application No. 10/509,697 (WIPO publication 03/087807)

    This device and method is an improvement of the countercurrent 
chromatography devices described above. This patent pending device is a 
new spiral design capable of holding heavier solvent systems suitable 
for peptides and proteins (e.g., for natural products).
    The prospective exclusive license will be royalty bearing and will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. 
The prospective exclusive license may be granted unless, within sixty 
(60) days from the date of this published notice, NIH receives written 
evidence and argument that establishes that the grant of the license 
would not be consistent with the requirements of 35 U.S.C. 209 and 37 
CFR 404.7.
    Properly filed competing applications for a license filed in 
response to this notice will be treated as objections to the 
contemplated license. Comments and objections submitted in response to 
this notice will not be made available for public inspection, and, to 
the extent permitted by law, will not be released under the Freedom of 
Information Act, 5 U.S.C. 552.

    Dated: January 12, 2007.
Steven M. Ferguson,
Director, Division of Technology Development and Transfer, Office of 
Technology Transfer, National Institutes of Health.
[FR Doc. 07-253 Filed 1-19-07; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.